Are you Dr. Bai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6411 Fannin St
Houston, TX 77030Phone+1 713-500-5300Fax+1 713-500-0730
Summary
- Dr. Yu Bai, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas and Virginia. She is affiliated with Memorial Hermann - Texas Medical Center and Memorial Hermann Physician Network.
Education & Training
University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical, 1999 - 2002- University of Virginia Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2000 - 2001
Beijing Medical UniversityClass of 1987
Certifications & Licensure
VA State Medical License 1998 - 2026
TX State Medical License 2005 - 2025- American Board of Pathology Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- Impact of Massive Transfusion Activation on Time to Delivery of the First Cooler and Patient Survival: A Study of 4,313 Consecutive Activations.Jan-Michael Van Gent, Devi Bavishi, Thomas W Clements, James B Dickey, Rhonda Hobbs
Journal of the American College of Surgeons. 2025-01-14 - DNMT1-driven methylation of RORA facilitates esophageal squamous cell carcinoma progression under hypoxia through SLC2A3.Wenjian Yao, Linlin Shang, Yinghao Wang, Lei Xu, Yu Bai
Journal of Translational Medicine. 2024-12-31 - 1 citationsEarly Cold Stored Platelet Transfusion Following Severe Injury: A Randomized Clinical Trial.Jason L Sperry, Francis X Guyette, Bedda L Rosario-Rivera, Matthew E Kutcher, Lucy Z Kornblith
Annals of Surgery. 2024-08-01
Press Mentions
Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled TrialNovember 18th, 2020- Prevalence of Gastric Cancer Precursors in Gastroscopy-Screened Adults by Family History of Gastric Cancer and of Cancers Other Than GastricNovember 16th, 2020
- Dizal Highlights Its Advances in Hematological Portfolio at 2023 ASH, Featuring Breakthroughs in Lymphoma TreatmentNovember 4th, 2023
- Join now to see all
